Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen-specific therapeutic approaches for autoimmunity
Pau Serra, Pere Santamaría
Nature Biotechnology (2019) Vol. 37, Iss. 3, pp. 238-251
Closed Access | Times Cited: 193

Showing 1-25 of 193 citing articles:

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Christina Krienke, LAURA D. KOLB, Elif Diken, et al.
Science (2021) Vol. 371, Iss. 6525, pp. 145-153
Closed Access | Times Cited: 349
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Lars Fugger, Lise T. Jensen, Jamie Rossjohn
Cell (2020) Vol. 181, Iss. 1, pp. 63-80
Closed Access | Times Cited: 273
Controlling timing and location in vaccines
Darrell J. Irvine, Aereas Aung, Murillo Silva
Advanced Drug Delivery Reviews (2020) Vol. 158, pp. 91-115
Open Access | Times Cited: 211
Treg Enhancing Therapies to Treat Autoimmune Diseases
Peter J. Eggenhuizen, Boaz H. Ng, Joshua D. Ooi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7015-7015
Open Access | Times Cited: 194
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, et al.
Gastroenterology (2021) Vol. 161, Iss. 1, pp. 66-80.e8
Open Access | Times Cited: 138
Rebalancing Immune Homeostasis to Treat Autoimmune Diseases
David A. Horwitz, Tarek M. Fahmy, Ciriaco A. Piccirillo, et al.
Trends in Immunology (2019) Vol. 40, Iss. 10, pp. 888-908
Open Access | Times Cited: 98
Tolerance in the Age of Immunotherapy
Jeffrey A. Bluestone, Mark S. Anderson
New England Journal of Medicine (2020) Vol. 383, Iss. 12, pp. 1156-1166
Open Access | Times Cited: 95
Tolerogenic nanoparticles suppress central nervous system inflammation
Jessica E. Kenison, Aditi Jhaveri, Zhaorong Li, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 50, pp. 32017-32028
Open Access | Times Cited: 80
Oligodendrocyte-derived extracellular vesicles as antigen-specific therapy for autoimmune neuroinflammation in mice
Giacomo Casella, Javad Rasouli, Alexandra Boehm, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 568
Open Access | Times Cited: 76
Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy
Cody D. Moorman, Sue J. Sohn, Hyewon Phee
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 74
Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation
Claudia Selck, Margarita Dominguez‐Villar
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
Thinking outside the box: non-canonical targets in multiple sclerosis
Laura Bierhansl, Hans‐Peter Hartung, Orhan Aktaş, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 578-600
Open Access | Times Cited: 68
A T follicular helper cell origin for T regulatory type 1 cells
Patricia Solé, Jun Yamanouchi, Josep Garnica, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 489-511
Open Access | Times Cited: 30
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
Yang Liu, Jun Li, Baowen Zhang, et al.
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Transcriptional control of dendritic cell development and functions
Lukas Amon, Christian H.K. Lehmann, Anna Barańska, et al.
International review of cell and molecular biology (2019), pp. 55-151
Closed Access | Times Cited: 65
A core–shell structure QRu-PLGA-RES-DS NP nanocomposite with photothermal response-induced M2 macrophage polarization for rheumatoid arthritis therapy
Xu Chen, Xufeng Zhu, Li‐Tao Ma, et al.
Nanoscale (2019) Vol. 11, Iss. 39, pp. 18209-18223
Closed Access | Times Cited: 61
Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals
Qi Liu, Xiang Wang, Xiangsheng Liu, et al.
ACS Nano (2020) Vol. 15, Iss. 1, pp. 1608-1626
Open Access | Times Cited: 54
Activation pathways that drive CD4+ T cells to break tolerance in autoimmune diseases*
S. Harsha Krovi, Vijay K. Kuchroo
Immunological Reviews (2022) Vol. 307, Iss. 1, pp. 161-190
Open Access | Times Cited: 31
Advances and Opportunities in Nanoparticle Drug Delivery for Central Nervous System Disorders: A Review of Current Advances
Chukwuyem Ekhator, Muhammad Qasim Qureshi, Abdul Wasay Zuberi, et al.
Cureus (2023)
Open Access | Times Cited: 21
Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Sean T. Carey, Christopher Bridgeman, Christopher M. Jewell
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 17
Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy
Qi Liu, Guoqiang Chen, Xingchi Liu, et al.
ACS Nano (2024)
Open Access | Times Cited: 6
Clinical Characteristics and Mechanisms of Acute Myocarditis
Stéphane Heymans, Sophie Van Linthout, Sarah Kraus, et al.
Circulation Research (2024) Vol. 135, Iss. 2, pp. 397-411
Closed Access | Times Cited: 6
Bibliometric and visualization analysis of the application of inorganic nanomaterials to autoimmune diseases
Baiyan Zhang, Yuanyuan Guo, Lu Yu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 3981-4005
Closed Access | Times Cited: 6
Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
Takashi Kishimoto
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top